CAI is confirmed to inhibit OXPHOS in cancer cells for the first time.
Anti-cancer effect of CAI is greatly improved by being combined with 2-DG.
ATP decrease and G2/M arrest are caused by the combination of CAI and 2-DG.
Combination of CAI and 2-DG is well-tolerated and effective in a xenograft model.
Combination of CAI and 2-DG may potentiate other metabolism targeting approaches.